Thursday, June 5, 2014

GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome | 2014 | Press releases | Media | GlaxoSmithKline


GSK announces start of phase III cardiovascular outcomes study with losmapimod in patients with acute coronary syndrome | 2014 | Press releases | Media | GlaxoSmithKline

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.